The Company obtained this rating for the seventeenth consecutive time, following an evaluation of the results obtained by analyzing
Contact:
Tel: +34 91 846 6000
Fax: 91 846 6001
(C) 2022 Electronic News Publishing, source
Market Closed -
Other stock markets
|
After market 01:33:11 pm | |||
33.3 EUR | +3.35% | 33.29 | -0.03% |
Apr. 23 | Pharma Mar, S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Feb. 29 | Transcript : Pharma Mar, S.A., 2023 Earnings Call, Feb 29, 2024 |
The Company obtained this rating for the seventeenth consecutive time, following an evaluation of the results obtained by analyzing
Contact:
Tel: +34 91 846 6000
Fax: 91 846 6001
(C) 2022 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
-18.94% | 612M | |
-2.61% | 88.47B | |
+3.55% | 40.71B | |
-14.07% | 32.43B | |
+55.89% | 24.28B | |
-16.21% | 15.52B | |
-41.29% | 12.17B | |
-15.46% | 12.01B | |
-11.75% | 12B | |
+7.87% | 8.87B |